Skip to content
10-K

Annual Report

CARDIFF ONCOLOGY, INC. CRDF

0001193125-26-067464

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 68.36M sh
Shares Diluted FY 2025 · Dec 31, 2025 66.84M sh
Shares Diluted FY 2025 · Dec 31, 2024 47.65M sh
Capex FY 2025 · Dec 31, 2025 $44K
Capex FY 2025 · Dec 31, 2024 $80K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$37.92M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$37.69M
Short Term Investments FY 2025 · Dec 31, 2025 $40.83M
Short Term Investments FY 2025 · Dec 31, 2024 $40.28M
Cash And Equivalents FY 2025 · Dec 31, 2025 $17.47M
Cash And Equivalents FY 2025 · Dec 31, 2024 $51.47M
Stockholders Equity FY 2025 · Dec 31, 2025 $45.39M
Stockholders Equity FY 2025 · Dec 31, 2024 $82.95M
Stockholders Equity FY 2025 · Dec 31, 2023 $69.74M
Current Liabilities FY 2025 · Dec 31, 2025 $16.39M
Current Liabilities FY 2025 · Dec 31, 2024 $13.43M
Total Liabilities FY 2025 · Dec 31, 2025 $16.5M
Total Liabilities FY 2025 · Dec 31, 2024 $14.24M
Current Assets FY 2025 · Dec 31, 2025 $60.13M
Current Assets FY 2025 · Dec 31, 2024 $95.05M
Total Assets FY 2025 · Dec 31, 2025 $61.88M
Total Assets FY 2025 · Dec 31, 2024 $97.19M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.69
Eps Diluted FY 2025 · Dec 31, 2024 −$0.95
Eps Basic FY 2025 · Dec 31, 2025 −$0.69
Eps Basic FY 2025 · Dec 31, 2024 −$0.95
Sga Expense FY 2025 · Dec 31, 2025 $14.22M
Sga Expense FY 2025 · Dec 31, 2024 $12.48M
Net Income FY 2025 · Dec 31, 2025 −$45.85M
Net Income FY 2025 · Dec 31, 2024 −$45.43M
Operating Income FY 2025 · Dec 31, 2025 −$48.96M
Operating Income FY 2025 · Dec 31, 2024 −$48.65M
Revenue FY 2025 · Dec 31, 2025 $593K
Revenue FY 2025 · Dec 31, 2024 $683K